MEN1 and pituitary adenomas

Annales d'Endocrinologie

Volumn 73, Issue 2, 2012, Pages 59-61

  Delemer, Brigitte ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; PROLACTIN;

ADENOMA; AGE DISTRIBUTION; ARTICLE; CANCER INVASION; CANCER RESISTANCE; CANCER SCREENING; CLINICAL FEATURE; CUSHING DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HYPOPHYSIS ADENOMA; MOLECULAR PATHOLOGY; MULTIPLE ENDOCRINE NEOPLASIA; ONSET AGE; PEDIATRICS; PROLACTINOMA;

ADENOMA; CHILD; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PITUITARY NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 84860915741     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.03.038     Document Type: Article

References (15)

1. Marini F., Falchetti A., Del Monte F., Carbonell Sala S., Gozzini A., Luzi E., et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2006, 1:38.
2. Thakker R.V. Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab 2010, 24(3):355-370.
3. Brandi M.L., Gagel R.F., Angeli A., Bilezikian J.P., Beck-Peccoz P., Bordi C., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86(12):5658-5671.
4. Goudet P., Murat A., Binquet C., Cardot-Bauters C., Costa A., Ruszniewski P., et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'étude des tumeurs endocrines) cohort study among 758 patients. World J Surg 2010, 34(2):249-255.
5. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276(5311):404-407.
6. Dreijerink K.M., Höppener J.W., Timmers H.M., Lips C.J. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation. Nat Clin Pract Endocrinol Metab 2006, 2(10):562-570.
7. Poncin J., Stevenaert A., Beckers A. Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur J Endocrinol 1999, 140(6):573-576.
8. Farrell W.E., Simpson D.J., Bicknell J., Magnay J.L., Kyrodimou E., Thakker R.V., et al. Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours. Br J Cancer 1999, 80(1-2):44-50.
9. Farrell W.E., Azevedo M.F., Batista D.L., Smith A., Bourdeau I., Horvath A., et al. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma. J Clin Endocrinol Metab 2011, 96(11):E1905-E1914.
10. Vergès B., Boureille F., Goudet P., Murat A., Beckers A., Sassolas G., et al. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002, 87(2):457-465.
11. Trouillas J., Labat-Moleur F., Sturm N., Kujas M., Heymann M.F., Figarella-Branger D., et al. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Am J Surg Pathol 2008, 32(4):534-543.
12. Olufemi S.E., Green J.S., Manickam P., Guru S.C., Agarwal S.K., Kester M.B., et al. Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. Hum Mutat 1998, 11(4):264-269.
13. Hao W., Skarulis M.C., Simonds W.F., Weinstein L.S., Agarwal S.K., Mateo C., et al. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. J Clin Endocrinol Metab 2004, 89(8):3776-3784.
14. Lourenço D.M., Toledo R.A., Mackowiak I.I., Coutinho F.L., Cavalcanti M.G., Correia-Deur J.E., et al. Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile. Eur J Endocrinol 2008, 159(3):259-274. [Epub 2008 Jun 4].
15. Stratakis C.A., Tichomirowa M.A., Boikos S., Azevedo M.F., Lodish M., Martari M., et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010, 78(5):457-463.